Relevant Financial Relationships: Dr McIntyre has received research grant support from CIHR/GACD/National Natural Science Foundation of China (NSFC) and the Milken Institute and speaker/consultation fees from Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Neurawell, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals, Viatris, Abbvie, Bristol Myers Squibb (BMS) Teva, Adhere Tech, GH Research, Autobahn Therapeutics, and Atai Life Sciences
Moffatt, B
The $149/mo membership charge is easy to miss if you only look at the medication price advertised on the page
After an average follow-up of nearly a year, people taking GLP-1 drugs were 8% less likely to need a CPAP machine to help treat their sleep apnea, results showed